Notification Form for Director in respect of Interests in Securities Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer Filing viewer · member access Original SGX announcement
Notification Form for Director in respect of Interests in Securities Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer Filing viewer · member access Original SGX announcement
FIRST SUBLINGUAL KETAMINE DRUG FOR TREATMENT OF ACUTE PAIN TO BE EVALUATED IN EOP2 MEETING WITH FDA General Announcement Filing viewer · member access Original SGX announcement
Third Quarter Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
Appointment of Chief Operating Officer Change - Announcement of Appointment Filing viewer · member access Original SGX announcement
PROPOSED DISPOSAL OF LABORATORY TESTING BUSINESS Asset Acquisitions and Disposals Filing viewer · member access Original SGX announcement
PROPOSED DISPOSAL OF LABORATORY TESTING BUSINESS Asset Acquisitions and Disposals Filing viewer · member access Original SGX announcement
Second Quarter and/ or Half Yearly Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
ISSUE AND ALLOTMENT OF NEW SHARES PURSUANT TO IX PERFORMANCE SHARE PLAN Employee Stock Option/ Share Scheme Filing viewer · member access Original SGX announcement
Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN REPL Filing viewer · member access Original SGX announcement
ISSUE AND ALLOTMENT OF NEW SHARES PURSUANT TO IX PERFORMANCE SHARE PLAN Employee Stock Option/ Share Scheme Filing viewer · member access Original SGX announcement
GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN Employee Stock Option/ Share Scheme Filing viewer · member access Original SGX announcement
First Quarter Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
CHANGES IN THE COMPOSITION OF THE BOARD AND REMUNERATION COMMITTEE General Announcement Filing viewer · member access Original SGX announcement
General Announcement::IX BIOPHARMA TO PRESENT WAFERMINE PHASE 2 STUDY RESULTS REPL Filing viewer · member access Original SGX announcement
IX BIOPHARMA TO PRESENT WAFERMINE PHASE 2 STUDY RESULTS General Announcement Filing viewer · member access Original SGX announcement
Retirement of Lead Independent Director Change - Announcement of Cessation Filing viewer · member access Original SGX announcement
Annual Reports and Related Documents:: Annual Reports and Related Documents Filing viewer · member access Original SGX announcement
UPDATE ANNOUNCEMENT ON PROPOSED SILDENAFIL RECLASSIFICATION General Announcement Filing viewer · member access Original SGX announcement
IX BIOPHARMA REPORTS POSITIVE RESULTS FROM WAFERMINE PHASE 2 MULTI-DOSE CLINICAL EFFICACY TRIAL General Announcement Filing viewer · member access Original SGX announcement
Full Yearly Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
APPROVAL OF FIRST CAPSULE SILDENAFIL DRUG FOR TREATMENT OF MALE ERECTILE DYSFUNCTION IN AUSTRALIA General Announcement Filing viewer · member access Original SGX announcement
CHANGE IN USE OF IPO PROCEEDS General Announcement Filing viewer · member access Original SGX announcement
